Liraglutide Versus Dapagliflozin for the Treatment of Patients with Type-2 Diabetes Mellitus in Spain- A Cost-Effectiveness Analysis
Abstract
Authors
A Ramírez de Arellano Serna P Mezquita-Raya G Vega-Hernandez R Wojcik M Schlueter